Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7521195 Lung disease targets and uses thereof

Patent 7521195 was granted and assigned to Celera Corporation on April, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Celera Corporation

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Aiqun Li0

Elizabeth Joseloff0

Steve Ruben0

Tao He0

Date of Patent

April 21, 2009

0

Patent Application Number

114903290

Date Filed

July 21, 2006

0

Patent Primary Examiner

0

Patent abstract

The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung diseases (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7521195 Lung disease targets and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.